HEALTH● LOWJul 28 · Jul 28, 2026, 5:55 PM
ProMIS jumps after early-stage trial data for Alzheimer’s therapy
Seeking Alpha Tech
A company's stock increased following the release of early-stage trial data for its Alzheimer's therapy. This news indicates a development in the medical treatment of Alzheimer's disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH28m agoRoche lung cancer drug extends survival by nearly six months in late-stage trialSeeking Alpha TechHEALTH37m agoJohnson & Johnson reports response rate for head, neck cancer treatmentSeeking Alpha TechHEALTH57m agoEbola: Day pandemic killed an Aláàfin, By Festus AdedayoPremium TimesHEALTH1h agoAgenus reports response rate in colon cancer trialSeeking Alpha Tech